Work

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival

Year: 2009

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428190902853136

Authors: Thomas C. Shea, Anne W. Beaven, Dominic T. Moore, Jonathan S. Serody, Don A. Gabriel, Nelson Chao, Jon P. Gockerman, Reynaldo A. Garcia, David A. Rizzieri

Institutions: University of North Carolina at Chapel Hill, University of North Carolina Health Care, UNC Lineberger Comprehensive Cancer Center, Duke Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Deutsches Krebsforschungszentrum, National Institutes of Health, National Center for Research Resources

Awards: G251702431, General Clinical Research Center, UNC Clinical and Translational Science Award

OpenAlex ID: W2082736279

FWCI: 0.63

Cites: 29

Cited by: 6

Related to: 10